Tryptanthrin Inhibits Angiogenesis by Targeting the VEGFR2-Mediated ERK1/2 Signalling PathwayXuemei Liao, K.N. Leung|PLoS ONE|2013Cited by 58
SPH3643: A novel cyclin‐dependent kinase 4/6 inhibitor with good anticancer efficacy and strong blood‐brain barrier permeabilityXuemei Liao, Yanjun Liu|Cancer Science|2020Cited by 18